FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Links shared publicly online about this topic.
- 1,070total visits
FDA Approves Merck's Dulera (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
View full resource at drugs.com
Tags: Asthma, FDA, Nasonex, Merck & Co.
Most Recently Shared on June 24, 2010 at 10:53 pm By:
FDA Approves Dulera (mometasone/formoterol) Inhalation Aerosol for the treatment of Asthma - http://bit.ly/d0eRIC
Dulera approved for the treatment of asthma - MPR
empr.com — “Merck announced that the FDA has approved Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 12 years of age.” View full resource at empr.com
Most Recently Shared on June 24, 2010 at 4:07 pm By:
MPR News: Dulera approved for the treatment of asthma: Merck announced that the FDA has approved Dulera (mometason... http://bit.ly/9I0Owb
Dulera approved for the treatment of asthma - ONA
oncologynurseadvisor.com — “Merck announced that the FDA has approved Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 12 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 24, 2010 at 3:33 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Dulera approved for the treatment of asthma http://goo.gl/fb/9fcWR
Advertisement
